NO168628C - Fremgangsmaate for fremstilling av perorale preparater inneholdende antidiabetiske sulfonylurea-forbindelser og/eller benzosyrederivater - Google Patents
Fremgangsmaate for fremstilling av perorale preparater inneholdende antidiabetiske sulfonylurea-forbindelser og/eller benzosyrederivaterInfo
- Publication number
- NO168628C NO168628C NO842290A NO842290A NO168628C NO 168628 C NO168628 C NO 168628C NO 842290 A NO842290 A NO 842290A NO 842290 A NO842290 A NO 842290A NO 168628 C NO168628 C NO 168628C
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- acid derivatives
- preparations containing
- compositions
- Prior art date
Links
- 230000003178 anti-diabetic effect Effects 0.000 title abstract 2
- 239000003472 antidiabetic agent Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 102000004877 Insulin Human genes 0.000 abstract 1
- 108090001061 Insulin Proteins 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 229940125396 insulin Drugs 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 239000003538 oral antidiabetic agent Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833320582 DE3320582A1 (de) | 1983-06-08 | 1983-06-08 | Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO842290L NO842290L (no) | 1984-12-10 |
| NO168628B NO168628B (no) | 1991-12-09 |
| NO168628C true NO168628C (no) | 1992-03-18 |
Family
ID=6200885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842290A NO168628C (no) | 1983-06-08 | 1984-06-07 | Fremgangsmaate for fremstilling av perorale preparater inneholdende antidiabetiske sulfonylurea-forbindelser og/eller benzosyrederivater |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US4696815A (fi) |
| EP (1) | EP0128483B1 (fi) |
| JP (1) | JPS6069038A (fi) |
| KR (1) | KR910004571B1 (fi) |
| AT (1) | ATE56365T1 (fi) |
| AU (1) | AU563642B2 (fi) |
| CA (1) | CA1228299A (fi) |
| DD (1) | DD224216A5 (fi) |
| DE (2) | DE3320582A1 (fi) |
| DK (1) | DK162019C (fi) |
| ES (1) | ES8506446A1 (fi) |
| FI (1) | FI85217C (fi) |
| GB (1) | GB2142236B (fi) |
| GR (1) | GR82362B (fi) |
| HK (1) | HK72387A (fi) |
| HU (1) | HU193932B (fi) |
| IE (1) | IE57793B1 (fi) |
| IL (1) | IL72034A (fi) |
| MY (1) | MY100795A (fi) |
| NO (1) | NO168628C (fi) |
| NZ (1) | NZ208417A (fi) |
| PH (1) | PH24567A (fi) |
| PT (1) | PT78710B (fi) |
| SG (1) | SG48187G (fi) |
| ZA (1) | ZA844296B (fi) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3320582A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung |
| DE3320583A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung |
| US5312924A (en) | 1983-12-30 | 1994-05-17 | Dr. Karl Thomae Gmbh | Phenylacetic acid benzylamides |
| US4819238A (en) * | 1987-10-26 | 1989-04-04 | Hughes Aircraft Company | Wide band free electron laser with variable phase and frequency |
| US5258185A (en) * | 1989-08-23 | 1993-11-02 | Bauer Kurt H | Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use |
| US5024843A (en) * | 1989-09-05 | 1991-06-18 | Alza Corporation | Oral hypoglycemic glipizide granulation |
| CH678920A5 (fi) * | 1989-11-14 | 1991-11-29 | Gergely Gerhard | |
| US6726930B1 (en) * | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
| US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
| WO1998001117A1 (en) | 1996-07-08 | 1998-01-15 | Edward Mendell Co., Inc. | Sustained release matrix for high-dose insoluble drugs |
| WO1999004818A1 (fr) * | 1997-07-24 | 1999-02-04 | Eisai Co., Ltd. | Composition pour preparation pharmaceutique et son procede de production |
| US6056977A (en) * | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
| US6099859A (en) | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
| US6099862A (en) | 1998-08-31 | 2000-08-08 | Andrx Corporation | Oral dosage form for the controlled release of a biguanide and sulfonylurea |
| IL143375A0 (en) * | 1999-09-30 | 2002-04-21 | Penwest Pharmaceuticals Co | Sustained release matrix systems for highly soluble drugs |
| US6703045B2 (en) | 2001-08-21 | 2004-03-09 | Council Of Scientific & Industrial Research | Composition and method for maintaining blood glucose level |
| WO2003026637A2 (en) * | 2001-09-28 | 2003-04-03 | Sun Pharmaceutical Industries Limited | Dosage form for treatment of diabetes mellitus |
| AU2002350719A1 (en) * | 2002-11-29 | 2004-06-23 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| WO2005023789A1 (en) * | 2003-09-10 | 2005-03-17 | Biocon Limited | Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid |
| AU2003269481A1 (en) * | 2003-09-10 | 2005-03-29 | Biocon Limited | (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt |
| TR200704897A1 (tr) | 2007-07-13 | 2009-02-23 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Uzatılmış salım sağlayan gliklazid formülasyonları@ |
| EP2181705A1 (en) | 2008-10-31 | 2010-05-05 | Disphar International B.V. | Sustained-release formulation of gliclazide |
| EP2468268B1 (en) | 2010-12-21 | 2017-12-13 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Combination composition of vildagliptin and gliclazide |
| TR201107482A1 (tr) | 2010-12-21 | 2012-07-23 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Vildagliptin ve gliklazidin iki tabakalı kombinasyon kompozisyonu. |
| TR201103946A1 (tr) | 2011-04-22 | 2012-11-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Kontrollü salım sağlayan gliklazid formülasyonları. |
| EP2779999A2 (en) | 2011-11-15 | 2014-09-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical formulations comprising atorvastatin and glimepiride |
| WO2014128116A1 (en) | 2013-02-19 | 2014-08-28 | Sanovel Ilac Sanayi Ve Ticaret A.S. | A production process for gliclazide formulations |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1187259A (en) * | 1967-10-23 | 1970-04-08 | Hexachimie | New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture |
| US3668215A (en) * | 1967-11-25 | 1972-06-06 | Bayer Ag | Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups |
| NL138933B (nl) * | 1969-03-26 | 1973-05-15 | Erba Carlo Spa | Werkwijze voor het bereiden van benzeensulfonylureumderivaten met bloedsuikerspiegelverlagende werking. |
| NL7314765A (fi) * | 1972-10-31 | 1974-05-02 | ||
| DE2657382A1 (de) * | 1976-12-17 | 1978-06-29 | Thera Ges Fuer Patente | Orales antidiabetikmittel |
| DE3175410D1 (en) * | 1980-07-29 | 1986-11-06 | Sanofi Sa | Acid stabilized compositions of thieno-pyridine derived compounds and process for preventing degradation of such compounds |
| US4430399A (en) * | 1980-09-25 | 1984-02-07 | Duracell Inc. | Method of electrode formation and article |
| DE3100535A1 (de) * | 1981-01-10 | 1982-08-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | "neue carbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel" |
| DE3225188A1 (de) * | 1982-07-06 | 1984-01-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue phenylessigsaeurederivate, ihre herstellung und diese verbindungen enthaltende arzneimittel |
| DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
| DE3126703A1 (de) * | 1981-07-07 | 1983-01-27 | Dr. Karl Thomae Gmbh, 7950 Biberach | Bromhexin-retardform und verfahren zu ihrer herstellung |
| GB2118040A (en) * | 1982-02-15 | 1983-10-26 | Hoechst Uk Ltd | Oral anti-diabetic preparation |
| DE3320582A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung |
-
1983
- 1983-06-08 DE DE19833320582 patent/DE3320582A1/de not_active Ceased
-
1984
- 1984-05-31 US US06/615,892 patent/US4696815A/en not_active Expired - Fee Related
- 1984-06-01 DE DE8484106272T patent/DE3483175D1/de not_active Expired - Fee Related
- 1984-06-01 AT AT84106272T patent/ATE56365T1/de not_active IP Right Cessation
- 1984-06-01 EP EP84106272A patent/EP0128483B1/de not_active Expired - Lifetime
- 1984-06-05 IL IL72034A patent/IL72034A/xx unknown
- 1984-06-06 DD DD84263871A patent/DD224216A5/de not_active IP Right Cessation
- 1984-06-06 GR GR74942A patent/GR82362B/el unknown
- 1984-06-07 NO NO842290A patent/NO168628C/no unknown
- 1984-06-07 ZA ZA844296A patent/ZA844296B/xx unknown
- 1984-06-07 KR KR1019840003188A patent/KR910004571B1/ko not_active IP Right Cessation
- 1984-06-07 GB GB08414529A patent/GB2142236B/en not_active Expired
- 1984-06-07 HU HU842206A patent/HU193932B/hu not_active IP Right Cessation
- 1984-06-07 ES ES533208A patent/ES8506446A1/es not_active Expired
- 1984-06-07 IE IE1423/84A patent/IE57793B1/en not_active IP Right Cessation
- 1984-06-07 NZ NZ208417A patent/NZ208417A/en unknown
- 1984-06-07 FI FI842294A patent/FI85217C/fi not_active IP Right Cessation
- 1984-06-07 CA CA000456096A patent/CA1228299A/en not_active Expired
- 1984-06-07 JP JP59117432A patent/JPS6069038A/ja active Granted
- 1984-06-07 DK DK281184A patent/DK162019C/da not_active IP Right Cessation
- 1984-06-08 AU AU29240/84A patent/AU563642B2/en not_active Ceased
- 1984-06-08 PT PT78710A patent/PT78710B/pt unknown
- 1984-06-08 PH PH30794A patent/PH24567A/en unknown
-
1987
- 1987-05-30 SG SG48187A patent/SG48187G/en unknown
- 1987-07-06 MY MYPI87000951A patent/MY100795A/en unknown
- 1987-07-23 US US07/076,697 patent/US4863724A/en not_active Expired - Lifetime
- 1987-10-07 HK HK723/87A patent/HK72387A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO168628C (no) | Fremgangsmaate for fremstilling av perorale preparater inneholdende antidiabetiske sulfonylurea-forbindelser og/eller benzosyrederivater | |
| DK280884A (da) | Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling |